Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.
about
Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infantsPropranolol treatment of subglottic hemangiomas: a review of the literatureCardiovascular drugs in the treatment of infantile hemangiomaPropranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapyEvaluation of the Compliance, Acceptance, and Usability of a Web-Based eHealth Intervention for Parents of Children With Infantile Hemangiomas: Usability Study.Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.Successful treatment of mild pediatric kasabach-merritt phenomenon with propranolol monotherapyBeta-blockers as therapy for infantile hemangiomasBeta blockers: an innovation in the treatment of infantile hemangiomas.Management of infantile hemangiomas: current trendsPropranolol Decreases Proliferation of Endothelial Cells Transformed by Kaposi's Sarcoma-Associated Herpesvirus and Induces Lytic Viral Gene Expression.Treatment of Infantile Hemangioma in Regional Hospitals With eHealth Support: Evaluation of Feasibility and Acceptance by Parents and Doctors.Monitoring propranolol treatment in periocular infantile haemangiomaRetrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study)A practical guide to treatment of infantile hemangiomas of the head and neck.Treatment of infantile haemangiomas: recommendations of a European expert group.Lymphatic Malformation, Retinoblastoma, or Facial Cleft: Atypical Presentations of PHACE Syndrome.Laser treatment of infantile hemangioma: A systematic review.Mechanisms of propranolol action in infantile hemangiomaEffective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report.Temperature Instability in an Infant Treated with Propranolol for Infantile Hemangioma.Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase RegulationOral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective studyPropranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakersTherapeutic Effect of Propranolol in Mexican Patients with Infantile HemangiomaInfantile hemangiomas and retinopathy of prematurity: clues to the regulation of vasculogenesis.GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.β1-Adrenergic receptor deficiency in ghrelin-expressing cells causes hypoglycemia in susceptible individuals.The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol.Excellent response of infantile orbital hemangioma to propranolol.Resolution of conjunctival sessile hemangioma with topical timolol.Neonatal Airway Compromise by a Giant Cervicothoracic Venous Haemangioma.Haemangioma: clinical course, complications and management.Propranolol for infantile haemangiomas: review of report of a consensus conference.Recent advances in paediatric dermatology.Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas.Educational paper: therapy of infantile haemangioma--history and current state (part II).The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.Incidence and treatment of infantile haemangioma in preterm infants.Multicenter Evaluation of the Effectiveness of Systemic Propranolol in the Treatment of Airway Hemangiomas.
P2860
Q24187442-F1BF1DD5-F544-4CE3-BD30-9083B1003281Q26765297-17F48421-B48D-4E2B-B177-B5920D18B6F9Q26769978-6795030F-B994-463E-8B9C-D8B5E54BE7D1Q27005682-F695B30E-51EE-4AD6-92C1-238FAF3DF7D4Q30486552-8E3E686E-3935-4C3A-B684-F5DB4599EE7EQ33577048-9CC130F0-55C8-49C9-94A6-651D9CA155FEQ33745400-3991AF32-DFF8-4DB7-9D54-6731A555DD0CQ33832594-DB714950-37D0-4730-BECF-A537F9BB7C93Q33931306-8B28FB21-BFDA-471C-860E-B2614773B036Q34052390-EA0F8C02-A029-48A7-B628-C22457A6797FQ34489319-AB514D84-6DAB-49A0-B2EB-F214434F1C64Q34657458-A5BDD66D-4661-492B-BFEA-55358C72BDB7Q34759656-021C54EF-BCD1-49DB-A5C4-A73AF304A88BQ35032888-DF8ECCE1-4698-405D-9914-C7852EAEE42BQ35049599-C3E67804-22A4-4B59-9BE4-EC10E3214F8DQ35645474-41BB3F99-448D-4C17-A143-26FB771C926EQ35843147-C92B9F4C-E8E1-4B08-A8C0-4A4FA5793870Q35879997-59384FA2-7CEE-45AF-A83C-DC33622B1129Q36085996-09523001-5B8E-459E-BE38-453A5FA3CD6AQ36086796-F961935E-0A64-4461-9388-B5A6E83D1A80Q36362590-E4410B60-1F7A-435F-B474-80335AC68E9BQ36440738-E63E6BD3-55FC-4B02-8DF8-548626EA135EQ36512006-F893DAD7-DF56-45F5-B86C-C5B5FBA483E7Q36673779-12B96A14-BD37-41D7-87BD-068882F526F5Q36761471-C45697EF-AA04-4DBA-9982-594809FFB9AAQ36875692-1548C445-12A4-4625-8C51-787F33FBC63DQ37153016-FBEC1276-B29D-4C4F-AF1D-693BF98748D9Q37217540-8FA75FC4-B445-4DD2-BC81-ED3FF500A83BQ37321874-745C331F-2223-482F-A9B6-0C9C82A7B21EQ37427098-92F5D048-44AF-4E8B-9DCC-A9A380A321D8Q37492417-EBF14C6D-4B10-4446-843B-CF8AEF3A55DAQ37734029-712F7287-CF2B-48A8-AEF8-03D7E39318E2Q38108844-FBA81443-FDC3-4A8A-B8C0-92074E7440F5Q38163411-E982B072-39CC-4425-B6E4-9E212D44AF7BQ38202032-6C4C5D4C-4414-4215-B745-B2DA1FFA0B9BQ38245087-57ACEFED-3923-49CE-844D-814E23CAD1B5Q38245341-BD94FB70-63E1-46BE-B225-DF0D28DCDF03Q38246692-B5CD0ED9-2FF7-467F-A635-4AE301374988Q38263431-6D72E331-C6D5-4177-B99D-12A3CCFAF1CBQ38540444-C3CE76F9-C456-427A-8FBD-E9D784ACED38
P2860
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Initiation and use of proprano ...... ort of a consensus conference.
@ast
Initiation and use of proprano ...... ort of a consensus conference.
@en
Initiation and use of proprano ...... ort of a consensus conference.
@nl
type
label
Initiation and use of proprano ...... ort of a consensus conference.
@ast
Initiation and use of proprano ...... ort of a consensus conference.
@en
Initiation and use of proprano ...... ort of a consensus conference.
@nl
prefLabel
Initiation and use of proprano ...... ort of a consensus conference.
@ast
Initiation and use of proprano ...... ort of a consensus conference.
@en
Initiation and use of proprano ...... ort of a consensus conference.
@nl
P2093
P2860
P50
P356
P1433
P1476
Initiation and use of proprano ...... port of a consensus conference
@en
P2093
Anthony J Mancini
Beth A Drolet
David H Darrow
Dawn H Siegel
Denise Metry
Eulalia Baselga
Eun-Kyung M Kwon
Francine Blei
Jonathan Perkins
Kari Martin
P2860
P304
P356
10.1542/PEDS.2012-1691
P407
P577
2012-12-24T00:00:00Z